Here's how to know if it's a fit for you.

Platform Expected to Target Expansion into Multi-Billion-Dollar Cardiovascular Market with Potential Class II Diagnostic Regulatory ...

The treatment of resistant hypertension has received a boost with the recent US Food and Drug Administration (FDA) approval of a completely new therapeutic approach that reduces activity in the ...

The hope is that renal denervation will solve not only hypertension-related complications but also the various problems associated with antihypertensive drugs that have a negative impact on quality of ...

PARIS, France—With renal denervation on the cusp of gaining a place in clinical practice for the treatment of hypertension, researchers are looking more closely at other conditions associated with ...

The Society for Cardiovascular Angiography and Interventions (SCAI) has released a proceedings document outlining the possible role of renal denervation (RDN) as a therapeutic option to complement ...

Denervation by catheter ablation, having broached the drug-intensive world of hypertension with some success, is venturing into a clinical realm that has repeatedly crushed attempts at medical therapy ...

Sympathetic tone and blood pressure are increased in patients with resistant hypertension and chronic kidney disease (CKD); the kidneys are a source of this increased sympathetic tone Renal ...

The data come from the NECTAR III and NECTAR IV (Neurotronic Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities) single-arm clinical studies, which evaluated ...

SAN FRANCISCO, CA—Even after antihypertensive agents were added back during the course of the RADIANCE trials, medication burden remained lower in the renal denervation arm than in the sham arm ...